Document Detail


Autocrine growth factor in defined serum-free medium of human salivary gland adenocarcinoma cell line HSG.
MedLine Citation:
PMID:  2788497     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Human salivary gland adenocarcinoma cell line HSG secretes an epidermal growth factor (EGF)-like molecule and contains EGF receptors. Growth of HSG cells is inhibited by glucocorticoid. We have identified that the growth inhibition by glucocorticoid is induced by the reduced secretion of the EGF-like molecule and that addition of anti-human EGF antibody to the culture specifically inhibits the growth of HSG cells, suggesting that autocrine secretion is involved in the growth of HSG cells. To prove that autocrine secretion functions in glucocorticoid-regulated growth of the HSG cell line, we purified the EGF-like molecule from serum-free, defined medium conditioned by the HSG cells and examined the growth-stimulatory effect of the purified molecule. The cultivation of HSG cells in serum-free defined medium, which contains insulin (10 micrograms/ml) and transferrin (10 micrograms/ml) only as proteinaceous components, resulted in establishment of a new cell line (HSG-SF) which had different morphological features from the parental HSG cell line. HSG-SF cells were found to have basically the same responsiveness to glucocorticoid as parental HSG cells. Parental HSG cells secreted high molecular weight EGF-like molecules (Mr 46,000 and 57,000), which were recognized by specific antibody to low molecular weight human EGF (Mr 6,201). From conditioned, serum-free medium of HSG-SF cells, an EGF-like molecule (Mr 46,000) was purified by using an anti-human EGF antibody-coupled Sepharose CL-4B column. This EGF-like molecule induced a maximal increase (36%) in incorporation of [3H]thymidine into DNA of parental HSG cells as well as low molecular weight human EGF. These observations demonstrate that growth of the HSG cell line is regulated by autocrine secretion.
Authors:
R Kurokawa; S Kyakumoto; M Ota
Related Documents :
11694457 - Retinoic acid protects against hyperoxia-mediated cell-cycle arrest of lung alveolar ep...
1357767 - Induction of tissue transglutaminase and apoptosis by retinoic acid in the limb bud.
9397987 - Presence of distinct ap-1 dimers in normal and transformed rat hepatocytes under basal ...
2912547 - Modulation of growth and epidermal growth factor receptor activity by retinoic acid in ...
19531027 - Human and rodent pancreatic beta-cells express il-4 receptors and il-4 protects against...
20379567 - Deformability considerations in filtration of biological cells.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Cancer research     Volume:  49     ISSN:  0008-5472     ISO Abbreviation:  Cancer Res.     Publication Date:  1989 Sep 
Date Detail:
Created Date:  1989-10-03     Completed Date:  1989-10-03     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  2984705R     Medline TA:  Cancer Res     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  5136-42     Citation Subset:  IM    
Affiliation:
Department of Biochemistry, Iwate Medical University School of Dentistry, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenocarcinoma / pathology*,  secretion
Cell Division / drug effects
Cell Line
Culture Media
DNA Replication / drug effects*
Epidermal Growth Factor / analysis,  secretion
Fibronectins / analysis,  secretion
Humans
Salivary Gland Neoplasms / pathology*,  secretion
Triamcinolone Acetonide / pharmacology*
Tumor Cells, Cultured / cytology,  drug effects
Chemical
Reg. No./Substance:
0/Culture Media; 0/Fibronectins; 62229-50-9/Epidermal Growth Factor; 76-25-5/Triamcinolone Acetonide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of doxorubicin on mouse hybridoma B cells: stimulation of immunoglobulin synthesis and secret...
Next Document:  Differences between in vivo and in vitro activation of cancer patient lymphocytes by recombinant int...